News
Blood clots are a silent threat behind many serious illnesses—from sepsis and cancer to viral infections and autoimmune disease. Now, inventors at the NIH National Cancer Institute (NCI) have identified a promising new way to stop dangerous clots before they spiral out of control, without increasing
The National Cancer Institute (NCI) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) are seeking licensees for a personalized tumor vaccine for cancer immunotherapy. Immunologically “cold” tumors have low T-cell infiltration whereas immunologically “hot
Register today for NCI’s webinar on an available COVID-19 vaccine that recently completed a study demonstrating how the vaccine prevented SARS-CoV-2 transmission and infection. Current SARS-CoV-2 vaccines utilize an intramuscular injection, while this technology combines an intramuscular injection
The National Cancer Institute (NCI) is seeking a collaboration partner for a COVID-19 therapeutic that will stop the infected cells from replicating inside a host. When SARS-CoV-2 enters a host, the cells replicate it and viral particles invade the nearby healthy cells. This happens because SARS-CoV